Gillian M. Shenfield

3.0k total citations
114 papers, 2.3k citations indexed

About

Gillian M. Shenfield is a scholar working on Pharmacology, Pediatrics, Perinatology and Child Health and Pharmacology. According to data from OpenAlex, Gillian M. Shenfield has authored 114 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Pharmacology, 20 papers in Pediatrics, Perinatology and Child Health and 18 papers in Pharmacology. Recurrent topics in Gillian M. Shenfield's work include Pharmacogenetics and Drug Metabolism (13 papers), Pharmaceutical studies and practices (13 papers) and Pharmaceutical Practices and Patient Outcomes (13 papers). Gillian M. Shenfield is often cited by papers focused on Pharmacogenetics and Drug Metabolism (13 papers), Pharmaceutical studies and practices (13 papers) and Pharmaceutical Practices and Patient Outcomes (13 papers). Gillian M. Shenfield collaborates with scholars based in Australia, United Kingdom and New Zealand. Gillian M. Shenfield's co-authors include James W. Paterson, Susan Ogle, Annette S. Gross, Margaret Duguid, John Boutagy, Beata Bajorek, Helen Wheeler, M E Evans, Philip A. Atkin and Ines Krass and has published in prestigious journals such as Journal of the American Geriatrics Society, Journal of Pharmacology and Experimental Therapeutics and Diabetologia.

In The Last Decade

Gillian M. Shenfield

113 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gillian M. Shenfield Australia 28 380 349 335 329 322 114 2.3k
Allan J. McLean Australia 29 619 1.6× 349 1.0× 356 1.1× 178 0.5× 351 1.1× 77 3.2k
Peter H. Vlasses United States 28 261 0.7× 359 1.0× 205 0.6× 227 0.7× 307 1.0× 176 2.9k
F. Andreasen Denmark 32 259 0.7× 381 1.1× 236 0.7× 337 1.0× 338 1.0× 107 2.8k
Micha Levy Israel 31 283 0.7× 494 1.4× 199 0.6× 207 0.6× 404 1.3× 51 3.5k
Hubert G.M. Leufkens Netherlands 23 230 0.6× 400 1.1× 221 0.7× 312 0.9× 398 1.2× 62 3.0k
Robert A. Blouin United States 29 769 2.0× 582 1.7× 261 0.8× 138 0.4× 478 1.5× 119 2.8k
John R. Horn United States 26 339 0.9× 326 0.9× 161 0.5× 163 0.5× 378 1.2× 118 2.8k
George R. Aronoff United States 32 184 0.5× 822 2.4× 182 0.5× 391 1.2× 411 1.3× 126 3.6k
Daniel Sitar Canada 35 605 1.6× 833 2.4× 374 1.1× 606 1.8× 813 2.5× 159 4.4k
Haleh Bagheri France 31 253 0.7× 479 1.4× 208 0.6× 169 0.5× 373 1.2× 176 3.0k

Countries citing papers authored by Gillian M. Shenfield

Since Specialization
Citations

This map shows the geographic impact of Gillian M. Shenfield's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gillian M. Shenfield with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gillian M. Shenfield more than expected).

Fields of papers citing papers by Gillian M. Shenfield

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gillian M. Shenfield. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gillian M. Shenfield. The network helps show where Gillian M. Shenfield may publish in the future.

Co-authorship network of co-authors of Gillian M. Shenfield

This figure shows the co-authorship network connecting the top 25 collaborators of Gillian M. Shenfield. A scholar is included among the top collaborators of Gillian M. Shenfield based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gillian M. Shenfield. Gillian M. Shenfield is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bajorek, Beata, Ines Krass, Susan Ogle, Margaret Duguid, & Gillian M. Shenfield. (2006). WARFARIN USE IN THE ELDERLY: THE NURSES’ PERSPECTIVE. Australian journal of advanced nursing. 23(3). 12 indexed citations
2.
Bajorek, Beata, Ines Krass, Susan Ogle, Margaret Duguid, & Gillian M. Shenfield. (2001). A Survey of Long‐Term Antiarrhythmic Therapy in Elderly Patients with Atrial Fibrillation. The Australian Journal of Hospital Pharmacy. 31(2). 93–97. 3 indexed citations
3.
Hoskins, Janelle M., Annette S. Gross, Gillian M. Shenfield, & Laurent P. Rivory. (2001). High-performance liquid chromatography–electrospray ionization mass spectrometry method for the measurement of moclobemide and two metabolites in plasma. Journal of Chromatography B Biomedical Sciences and Applications. 754(2). 319–326. 15 indexed citations
4.
Hoskins, Janelle M., et al.. (2001). Characterization of moclobemideN-oxidation in human liver microsomes. Xenobiotica. 31(7). 387–397. 14 indexed citations
5.
Shenfield, Gillian M., et al.. (2001). Recording previous adverse drug reactions—a gap in the system. British Journal of Clinical Pharmacology. 51(6). 623–626. 24 indexed citations
6.
Shenfield, Gillian M., et al.. (1999). PROGUANIL OXIDATION IN A CHINESE POPULATION. Therapeutic Drug Monitoring. 21(4). 476–476. 1 indexed citations
7.
Shenfield, Gillian M. & Annette S. Gross. (1999). The cytochrome P450 system and adverse drug reactions. Adverse Drug Reaction Bulletin. 194(1). 739–742. 5 indexed citations
8.
Shenfield, Gillian M.. (1998). Integrating clinical pharmacology teaching with general practice. British Journal of Clinical Pharmacology. 45(4). 399–401. 3 indexed citations
9.
Atkin, Philip A., et al.. (1997). Use of Alternative Medicines on Sydney's North Shore. The Australian Journal of Hospital Pharmacy. 27(5). 367–372. 18 indexed citations
10.
Shenfield, Gillian M., et al.. (1997). History in the making: the evolution of consumer product information (CPI). The Medical Journal of Australia. 166(8). 425–428. 3 indexed citations
11.
Atkin, Philip A., et al.. (1995). Are medication record cards useful?. The Medical Journal of Australia. 162(6). 300–301. 11 indexed citations
12.
Shenfield, Gillian M., et al.. (1980). Effect of restrictions on prescribing patterns for dextropropoxyphene.. BMJ. 281(6241). 651–653. 25 indexed citations
13.
Shenfield, Gillian M., et al.. (1980). Pregnancy attributable to interaction between tetracycline and oral contraceptives.. BMJ. 280(6210). 293.1–293. 59 indexed citations
14.
Madsen, Barry W., et al.. (1978). Clinical trial experience by simulation: a workshop report.. BMJ. 2(6148). 1333–1335. 6 indexed citations
15.
Steel, J M, Gillian M. Shenfield, & L. J. P. Duncan. (1976). Rapid onset of proliferative retinopathy in young insulin-independent diabetics.. BMJ. 2(6040). 852–852. 8 indexed citations
16.
Shenfield, Gillian M., G.K. Knowles, Nicole Thomas, & James W. Paterson. (1975). Potassium supplements in patients treated with corticosteroids. British Journal of Diseases of the Chest. 69. 171–176. 4 indexed citations
17.
Evans, M E, Gillian M. Shenfield, Nicole Thomas, Stuart Walker, & James W. Paterson. (1974). The Pharmacokinetics of Rimiterol in Man. Xenobiotica. 4(11). 681–692. 17 indexed citations
18.
Shenfield, Gillian M. & James W. Paterson. (1973). Clinical assessment of bronchodilator drugs delivered by aerosol. Thorax. 28(2). 124–128. 56 indexed citations
19.
Hart, F. Dudley, et al.. (1971). Overdosage of tetracosactrin in rheumatoid arthritis.. BMJ. 2(5754). 165.1–165. 2 indexed citations
20.
Shenfield, Gillian M. & C J Spry. (1968). Unusual Cause of Agranulocytosis. BMJ. 2(5596). 52.4–53. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Allan J. McLean Breakdown of academic impact, for papers by Peter H. Vlasses Breakdown of academic impact, for papers by F. Andreasen Breakdown of academic impact, for papers by Micha Levy Breakdown of academic impact, for papers by Hubert G.M. Leufkens Breakdown of academic impact, for papers by Robert A. Blouin Breakdown of academic impact, for papers by John R. Horn Breakdown of academic impact, for papers by George R. Aronoff Breakdown of academic impact, for papers by Daniel Sitar Breakdown of academic impact, for papers by Haleh Bagheri
Rankless by CCL
2026